More DailyStrength
Health Event Calendar
See what's new on the site
Step-by-step Tutorials
How to use DailyStrength
We're on Facebook
Check out our page
Follow us on Twitter
Read our tweets
Get Cool DS Stuff!!!!!
Shirts, Hats, Baby Wear
FDA, on the clinical hold related to sovaprevir,
Watch this 
View More Posts Ignore
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) provided an update on development of compounds in its pipeline of therapies for the treatment of chronic hepatitis C virus, or HCV. Achillion today received a response from the U. S. Food and Drug Administration, or FDA, on the clinical hold related to sovaprevir, Achillion's NS3 protease inhibitor. The FDA response indicated that, while Achillion's submission addressed all issues noted in the FDA'sJune 29, 2013 letter, the FDA concluded that the removal of the clinical hold is not warranted.
Posted on 10/10/13, 10:28 pm
2 Replies Add Your Reply
Reminder: This is a support group for Hepatitis C. We trust you will do your best to remain positive and helpful. For more information, see our rules of the road.

You may also create your own Member Groups where you can moderate the discussion.
Email me when others reply to this topic help
View More Posts Ignore
Reply #1 - 10/10/13  10:33pm
" Thankfully its not Simeprevir or Sofsbuvir! "
View More Posts Ignore
Reply #2 - 10/11/13  11:06am
" ok...they ALL end in VIR..but why do do many have to start with "S"? my brains is to dulled to keep them straight. "

Add Your Reply

More From Around the Web